Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells

Stem Cells and Development

Volumn 20, Issue 7, 2011, Pages 1131-1142

  Seiler, Katharina ^a   Soroush Noghabi, Monireh ^b   Karjalainen, Klaus ^b   Hummel, Michael ^c   Melchers, Fritz ^a   Tsuneto, Motokazu ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STANDARDIZATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; GERM LAYERS; HEMATOPOIETIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; OCTAMER TRANSCRIPTION FACTOR-3; SOXB1 TRANSCRIPTION FACTORS; TERATOMA;

IPS;

EID: 79959844754     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0391     Document Type: Article

References (53)

1. Antonchuk J, G Sauvageau and RK Humphries. (2001). HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp Hematol 29:1125-1134. (Pubitemid 32781004)
2. Kyba M, RC Perlingeiro and GQ Daley. (2002). HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109:29-37. (Pubitemid 34327514)
3. Wang Y, F Yates, O Naveiras, P Ernst and GQ Daley. (2005). Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci USA 102:19081-19086. (Pubitemid 43049569)
4. Bonde S, KM Chan and N Zavazava. (2008). ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS ONE 3:e3212.
5. Chan KM, S Bonde, H Klump and N Zavazava. (2008). Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood 111:2953-2961.
6. Matsumoto K, T Isagawa, T Nishimura, T Ogaeri, K Eto, S Miyazaki, J Miyazaki, H Aburatani, H Nakauchi and H Ema. (2009). Stepwise development of hematopoietic stem cells from embryonic stem cells. PLoS ONE 4:e4820.
7. Aoi T, K Yae, M Nakagawa, T Ichisaka, K Okita, K Takahashi, T Chiba and S Yamanaka. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699-702.
8. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, R Jaenisch, K Plath and K Hochedlinger. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
9. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
10. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317. (Pubitemid 47080336)
11. Stadtfeld M, N Maherali, DT Breault and K Hochedlinger. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2:230-240.
12. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
13. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324. (Pubitemid 47080337)
14. Mikkelsen TS, J Hanna, X Zhang, M Ku, M Wernig, P Schorderet, BE Bernstein, R Jaenisch, ES Lander and A Meissner. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454:49-55. (Pubitemid 351931978)
15. Deng J, R Shoemaker, B Xie, A Gore, EM LeProust, J Antosiewicz- Bourget, D Egli, N Maherali, IH Park, J Yu, GQ Daley, K Eggan, K Hochedlinger, J Thomson, W Wang, Y Gao and K Zhang. (2009). Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 27:353-360.
16. Doi A, IH Park, B Wen, P Murakami, MJ Aryee, R Irizarry, B Herb, C Ladd-Acosta, J Rho, S Loewer, J Miller, T Schlaeger, GQ Daley and AP Feinberg. (2009). Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41:1350-1353.
17. Pick M, Y Stelzer, O Bar-Nur, Y Mayshar, A Eden and N Benvenisty. (2009). Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27:2686-2690.
18. Chin MH, MJ Mason, W Xie, S Volinia, M Singer, C Peterson, G Ambartsumyan, O Aimiuwu, L Richter, J Zhang, I Khvorostov, V Ott, M Grunstein, N Lavon, N Benvenisty, CM Croce, AT Clark, T Baxter, AD Pyle, MA Teitell, M Pelegrini, K Plath and WE Lowry. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111-123.
19. Marchetto MC, GW Yeo, O Kainohana, M Marsala, FH Gage and AR Muotri. (2009). Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 4:e7076.
20. Stadtfeld M, E Apostolou, H Akutsu, A Fukuda, P Follett, S Natesan, T Kono, T Shioda and K Hochedlinger. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465:175-181.
21. Wilson KD, S Venkatasubrahmanyam, F Jia, N Sun, AJ Butte and JC Wu. (2009). MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 18:749-758.
22. Schenke-Layland K, KE Rhodes, E Angelis, Y Butylkova, S Heydarkhan-Hagvall, C Gekas, R Zhang, JI Goldhaber, HK Mikkola, K Plath and WR MacLellan. (2008). Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26:1537-1546.
23. Grigoriadis AE, M Kennedy, A Bozec, F Brunton, G Stenbeck, IH Park, EF Wagner and GM Keller. (2010). Directed differentiation of hematopoietic precursors and functional osteoclasts fromhuman ES and iPS cells. Blood 115:2769-2776.
24. Nakano T, H Kodama and T Honjo. (1994). Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265:1098-1101. (Pubitemid 24293078)
25. Nishikawa S, M Ogawa, S Nishikawa, T Kunisada and H Kodama. (1988). B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur J Immunol 18:1767-1771. (Pubitemid 19011585)
26. Li E, TH Bestor and R Jaenisch. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
27. Kontgen F, G Suss, C Stewart, M Steinmetz and H Bluethmann. (1993). Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol 5:957-964. (Pubitemid 23241767)
28. Karasuyama H and F Melchers. (1988). Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 18:97-104. (Pubitemid 18072702)
29. Winkler TH, F Melchers and AG Rolink. (1995). Interleukin- 3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood 85:2045-2051.
30. Rolink A, F Melchers and J Andersson. (1996). The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5:319-330. (Pubitemid 26366755)
31. Kitamura T, Y Koshino, F Shibata, T Oki, H Nakajima, T Nosaka and H Kumagai. (2003). Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31:1007-1014. (Pubitemid 37329742)
32. Morita S, T Kojima and T Kitamura. (2000). Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066. (Pubitemid 30398356)
33. Doetschman TC, H Eistetter, M Katz, W Schmidt and R Kemler. (1985). The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45. (Pubitemid 15029925)
34. Wiles MV and G Keller. (1991). Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111:259-267. (Pubitemid 21920413)
35. Mizrahi A. (1977). Primatone RL in mammalian cell culture media. Biotechnol Bioeng 19:1557-1561.
36. Tsuneto M, A Tominaga, H Yamazaki, M Yoshino, SH Orkin and S Hayashi. (2005). Enforced expression of PU.1 rescues osteoclastogenesis from embryonic stem cells lacking Tal-1. Stem Cells 23:134-143. (Pubitemid 40105299)
37. Ruedl C, HJ Khameneh and K Karjalainen. (2008). Manipulation of immune system via immortal bone marrow stem cells. Int Immunol 20:1211-1218.
38. O'Connor MD, MD Kardel, I Iosfina, D Youssef, M Lu, MM Li, S Vercauteren, A Nagy and CJ Eaves. (2008). Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 26:1109-1116.
39. Neri T, M Monti, P Rebuzzini, V Merico, S Garagna, CA Redi and M Zuccotti. (2007). Mouse fibroblasts are reprogrammed to Oct-4 and Rex-1 gene expression and alkaline phosphatase activity by embryonic stem cell extracts. Cloning Stem Cells 9:394-406.
40. Mitsui K, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K Takahashi, M Maruyama, M Maeda and S Yamanaka. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642. (Pubitemid 36694188)
41. Evans MJ and MH Kaufman. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156. (Pubitemid 11050741)
42. Nakano T. (2003). Hematopoietic stem cells: generation and manipulation. Trends Immunol 24:589-594. (Pubitemid 37338527)
43. Trapani JA and MJ Smyth. (2002). Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735-747. (Pubitemid 37328714)
44. Eichmann A, C Corbel, V Nataf, P Vaigot, C Breant and NM Le Douarin. (1997). Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci USA 94:5141-5146. (Pubitemid 27214750)
45. Millauer B, S Wizigmann-Voos, H Schnurch, R Martinez, NP Moller, W Risau and A Ullrich. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846. (Pubitemid 23110226)
46. Ferkowicz MJ, M Starr, X Xie, W Li, SA Johnson, WC Shelley, PR Morrison and MC Yoder. (2003). CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 130:4393-4403. (Pubitemid 37185327)
47. Li W, MJ Ferkowicz, SA Johnson, WC Shelley and MC Yoder. (2005). Endothelial cells in the early murine yolk sac give rise to CD41-expressing hematopoietic cells. Stem Cells Dev 14:44-54. (Pubitemid 40328247)
48. Mikkola HK, Y Fujiwara, TM Schlaeger, D Traver and SH Orkin. (2003). Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood 101:508-516. (Pubitemid 36082842)
49. Kabrun N, HJ Buhring, K Choi, A Ullrich, W Risau and G Keller. (1997). Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:2039-2048. (Pubitemid 27270272)
50. Okuyama H, M Tsuneto, T Yamane, H Yamazaki and S Hayashi. (2003). Discrete types of osteoclast precursors can be generated from embryonic stem cells. Stem Cells 21:670-680. (Pubitemid 37329160)
51. Varas F, A Bernard and JA Bueren. (1998). Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors. Exp Hematol 26:100-109. (Pubitemid 28079053)
52. Nishi N, M Osawa, R Ishikawa, M Nishikawa, H Tsumura, H Inoue and T Sudo. (1995). Hematopoietic stem cells found in lineage-positive subsets in the bone marrow of 5-fluorouracil- treated mice. Stem Cells 13:517-523.
53. Choi KD, J Yu, K Smuga-Otto, G Salvagiotto,WRehrauer, M Vodyanik, J Thomson and I Slukvin. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559-567.